Frequently Asked Questions
1. What is immunotherapy for prostate cancer?
Immunotherapy is an advanced treatment that stimulates the body’s immune system to recognize and attack prostate cancer cells. Options may include therapeutic cancer vaccines, checkpoint inhibitors, and targeted biologics.
2. Who is eligible for immunotherapy?
It is generally recommended for patients with advanced, recurrent, or treatment-resistant prostate cancer. Eligibility depends on cancer stage, overall health, and medical history, assessed by specialists.
3. How is immunotherapy given?
Depending on the type, immunotherapy may be administered through intravenous infusions, injections, or oral medications. Our team ensures patients are guided safely through the entire process.
4. What side effects should I expect?
Common side effects can include fatigue, flu-like symptoms, skin reactions, or mild inflammation. These are closely monitored and managed by our medical specialists to maintain safety and comfort.
5. How long does the treatment take?
The duration varies based on the treatment type and patient response. Some patients may undergo therapy for several weeks or months with scheduled monitoring and follow-ups.
6. Can immunotherapy be combined with other treatments?
Yes. Immunotherapy can be combined with hormone therapy, radiation, or targeted therapies to enhance effectiveness, depending on the patient’s condition.
7. How do I schedule a consultation?
You can easily book a consultation with our prostate cancer specialists to discuss treatment options and create a personalized care plan.
8. Is immunotherapy covered by insurance?
Insurance coverage varies depending on your provider and plan. Our patient care team assists with financing options and guides you through insurance queries.